SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-078952
Filing Date
2021-06-09
Accepted
2021-06-09 18:51:22
Documents
1
Period of Report
2021-06-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2118093-9_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2118093-9_4seq1.xml 4 3545
  Complete submission text file 0001104659-21-078952.txt   5108
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RUNGSTED STRANDVEJ 113 RUNGSTED KYST G7 2960
Business Address RUNGSTED STRANDVEJ 113 RUNGSTED KYST G7 2960 45-45-17-77-77
WG Biotech ApS (Reporting) CIK: 0001753193 (see all company filings)

State of Incorp.: G7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38650 | Film No.: 211006390